Bio Path Holdings Inc

NASDAQ: BPTH
$0.82
+$0.02 (+2.6%)
Closing Price on November 22, 2024

BPTH Stock Chart and Intraday Price

BPTH Stock Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector TRADE & SERVICES
Industry RETAIL-MISCELLANEOUS SHOPPING GOODS STORES
Address 2626 SOUTH LOOP, SUITE 180, HOUSTON, TX, US
Fiscal Year End December
Latest Quarter 2023-12-31
Market Cap 2.92M USD
Shares Outstanding 678,800
Bio-Path Holdings, Inc. is an RNAi nanoparticle drug development company focused on preclinical and clinical stage oncology in the United States. The company is headquartered in Bellaire, Texas.

BPTH Articles

Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way that management and the board of directors has handled it has been clumsy.
Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials often fail, so investors need to gamble that one or more of its treatments...
What is it like to have a stock plunge 90% in less than a year and wipe out a huge amount of shareholder value? That's what happened to Bio-Path.